Targeting NF-κB-inducing kinase (NIK) in the non-canonical pathway: Advances in the development of NIK inhibitors
Authors:
- 17 November 2025
- journal article
- review article
- Published by Elsevier in Bioorganic Chemistry
- Vol. 167, 109247
Abstract
No abstract availableKeywords
Funding Information
- Anhui Medical University (2023xktdyxa2)
- Anhui Provincial Department of Education (2022AH050654)
This publication has 85 references indexed in Scilit:
- Identification and study of new NF‐κB‐inducing kinase ligands derived from the imidazolone scaffoldArchiv der Pharmazie, 2024
- NF-κB-Inducing Kinase Provokes Insulin Resistance in Skeletal Muscle of Obese MiceInflammation, 2023
- Filling a nick in NIK: Extending the half-life of a NIK inhibitor through structure-based drug designBioorganic & Medicinal Chemistry Letters, 2023
- The discovery of quinoline derivatives, as NF-κB inducing kinase (NIK) inhibitors with anti-inflammatory effects in vitro, low toxicities against T cell growthBioorganic & Medicinal Chemistry, 2021
- A novel inhibitor of NF-κB-inducing kinase prevents bone loss by inhibiting osteoclastic bone resorption in ovariectomized miceBone, 2020
- Identification of new NIK inhibitors by discriminatory analysis‐based molecular docking and biological evaluationArchiv der Pharmazie, 2019
- NF-kappaB-inducing kinase in cancerBiochimica et Biophysica Acta (BBA) - Reviews on Cancer, 2019
- Inhibiting NF-κB-inducing kinase (NIK): Discovery, structure-based design, synthesis, structure–activity relationship, and co-crystal structuresBioorganic & Medicinal Chemistry Letters, 2013
- Shared Principles in NF-κB SignalingCell, 2008
- Multiple nuclear factors interact with the immunoglobulin enhancer sequencesCell, 1986